Related Experiment Videos
Lentiviral transgenesis--a versatile tool for basic research and gene therapy.
1Department of Pharmacy/Center for Drug Research, Molecular Pharmacology, Butenandtstr. 5 (C), Ludwig-Maximilians University of Munich, Germany. alexander.pfeifer@cup.uni-muenchen.de
Current Gene Therapy
|August 22, 2006
Summary
Lentiviral transgenesis efficiently creates transgenic animals for disease modeling and gene therapy. This method enables gene silencing via RNA interference, advancing biomedical research and therapeutic development.
Area of Science:
- Biomedical Sciences
- Genetics
- Molecular Biology
Background:
- Transgenic animals are crucial for modeling human diseases and developing gene therapies.
- Lentiviral transgenesis offers an efficient method for generating transgenic animals.
Purpose of the Study:
- To highlight the applications and extensions of lentiviral transgenesis in biomedical research.
- To discuss the use of lentiviral vectors for gene therapy evaluation.
Main Methods:
- Generation of transgenic animals through lentiviral transduction of oocytes or early embryos.
- Combination of lentiviral gene transfer with RNA interference for gene silencing.
Main Results:
- Lentiviral transgenesis is effective in mice, rats, and livestock.
- This technology facilitates the creation of disease models and gene-pharmimg.
- Gene silencing using lentiviral vectors allows for the generation of loss-of-function models.
Conclusions:
- Lentiviral transgenesis is a versatile tool for creating disease models and advancing gene therapy strategies.
- The integration of RNA interference expands the utility of lentiviral vectors for functional genomics.
- Transgenic animals produced via lentiviral methods serve as valuable platforms for preclinical evaluation of gene therapies.